0001161697-22-000606.txt : 20221229 0001161697-22-000606.hdr.sgml : 20221229 20221229164755 ACCESSION NUMBER: 0001161697-22-000606 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221227 FILED AS OF DATE: 20221229 DATE AS OF CHANGE: 20221229 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Harper Molly CENTRAL INDEX KEY: 0001871470 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33057 FILM NUMBER: 221499317 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001369568 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 BUSINESS PHONE: (305) 529-2522 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 FORMER COMPANY: FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC. DATE OF NAME CHANGE: 20110215 FORMER COMPANY: FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc. DATE OF NAME CHANGE: 20060719 4 1 form_4.xml FORM 4 FOR 12-27-2022 X0306 4 2022-12-27 0 0001369568 CATALYST PHARMACEUTICALS, INC. CPRX 0001871470 Harper Molly 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 1 0 0 0 Options to purchase common stock 18.59 2022-12-27 4 A 0 15000 0 A 2029-12-27 Common Stock 15000 107000 D Restricted Stock Units 2022-12-27 4 A 0 4000 0 A Common Stock 4000 111000 D Derivative securities vest in equal tranches, 1/3rd on December 27, 2023, 1/3rd on December 27, 2024 and 1/3rd on December 27, 2025. Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting. Shares of common stock will be delivered to the Reporting Person upon vesting. /s/ Molly Harper 2022-12-29